These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34907060)

  • 1. Health actor approaches to financing universal coverage strategies for pneumococcal and rotavirus immunisation programmes in low-income and middle-income countries: a scoping review protocol.
    Ogundele OJ; Fadel S; Braitstein P; Di Ruggiero E
    BMJ Open; 2021 Dec; 11(12):e052381. PubMed ID: 34907060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital technologies for health financing in low-income and middle-income countries: a scoping review protocol.
    Pioch C; Struckmann V; Brikci N; De Allegri M; Emmrich JV; Knauss S; Mathauer I; Opoku D; Quentin W
    BMJ Open; 2024 Jun; 14(6):e080132. PubMed ID: 38834327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engaging Canadians in evidence-based communication about vaccines: a scoping review protocol of immunisation support programs in Canada.
    Kelly KJ; Mears K; Burns M; Montelpare W
    BMJ Open; 2022 Apr; 12(4):e060103. PubMed ID: 35450915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs of introducing pneumococcal, rotavirus and a second dose of measles vaccine into the Zambian immunisation programme: Are expansions sustainable?
    Griffiths UK; Bozzani FM; Chansa C; Kinghorn A; Kalesha-Masumbu P; Rudd C; Chilengi R; Brenzel L; Schutte C
    Vaccine; 2016 Jul; 34(35):4213-4220. PubMed ID: 27371102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for a scoping review of implementation research approaches to universal health coverage in Africa.
    Nnaji CA; Wiysonge CS; Okeibunor J; Malinga T; Adamu AA; Tumusiime P; Karamagi H
    BMJ Open; 2021 Feb; 11(2):e041721. PubMed ID: 33589452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.
    Madsen LB; Ustrup M; Hansen KS; Nyasulu PS; Bygbjerg IC; Konradsen F
    Trop Med Int Health; 2014 Feb; 19(2):177-85. PubMed ID: 24314006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global rotavirus vaccine introductions and coverage: 2006 - 2016.
    Abou-Nader AJ; Sauer MA; Steele AD; Tate JE; Atherly D; Parashar UD; Santosham M; Nelson EAS
    Hum Vaccin Immunother; 2018; 14(9):2281-2296. PubMed ID: 29787334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocol.
    Kagina BM; Wiysonge CS; Machingaidze S; Abdullahi LH; Adebayo E; Uthman OA; Hussey GD
    BMJ Open; 2014 Feb; 4(2):e004429. PubMed ID: 24549166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
    Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
    Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.
    Marijam A; Schuerman L; Izurieta P; Pereira P; Van Oorschot D; Mehta S; Ota MO; Standaert B
    Hum Vaccin Immunother; 2022 Dec; 18(7):2135916. PubMed ID: 36507685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicomponent interventions to improve routine childhood vaccine uptake in low and middle-income countries: a scoping review protocol.
    Mohamed Y; Danchin M; Kaufman J
    BMJ Open; 2023 Sep; 13(9):e075414. PubMed ID: 37758679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outstanding challenges for rotavirus vaccine introduction in low-income countries--a systematic review.
    Ustrup M; Madsen LB; Bygbjerg IC; Konradsen F
    Dan Med Bull; 2011 Oct; 58(10):A4323. PubMed ID: 21975154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for improving coverage of childhood immunisation in low- and middle-income countries.
    Oyo-Ita A; Oduwole O; Arikpo D; Effa EE; Esu EB; Balakrishna Y; Chibuzor MT; Oringanje CM; Nwachukwu CE; Wiysonge CS; Meremikwu MM
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD008145. PubMed ID: 38054505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustainability of National Immunization Programme (NIP) performance and financing following Global Alliance for Vaccines and Immunization (GAVI) support to the Democratic Republic of the Congo (DRC).
    Le Gargasson JB; Breugelmans JG; Mibulumukini B; Da Silva A; Colombini A
    Vaccine; 2013 Apr; 31(15):1886-91. PubMed ID: 23462529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.
    Williams BA; Kidane T; Chirwa G; Tesfaye N; Prescott MR; Scotney ST; Valle M; Abebe S; Tambuli A; Malewezi B; Mohammed T; Kobayashi E; Wootton E; Wong R; Dosani R; Subramaniam H; Joseph J; Yavuz E; Apple A; Le Tallec Y; Kang'ethe A
    Health Policy Plan; 2016 Jun; 31(5):563-72. PubMed ID: 26856361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond.
    Chen S; Rodewald LE; Du AH; Tang S
    Infect Dis Poverty; 2024 Mar; 13(1):25. PubMed ID: 38475849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare system.
    Loganathan T; Jit M; Hutubessy R; Ng CW; Lee WS; Verguet S
    Trop Med Int Health; 2016 Nov; 21(11):1458-1467. PubMed ID: 27503549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and timeliness of rotavirus vaccination in Norway: The first year post-introduction.
    Valcarcel Salamanca B; Hagerup-Jenssen ME; Flem E
    Vaccine; 2016 Sep; 34(39):4684-4689. PubMed ID: 27522178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exemplars in vaccine delivery protocol: a case-study-based identification and evaluation of critical factors in achieving high and sustained childhood immunisation coverage in selected low-income and lower-middle-income countries.
    Bednarczyk RA; Hester KA; Dixit SM; Ellis AS; Escoffery C; Kilembe W; Micek K; Sakas ZM; Sarr M; Freeman MC
    BMJ Open; 2022 Apr; 12(4):e058321. PubMed ID: 35487707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.